Top compounds associated with response to TSPY2


Feature Type Standardized
Nominal ANOVA
mRNA BMS-536924 CTRPv2 pan-cancer AAC -0.073 0.04
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.067 0.04
mRNA BRD-K07442505 CTRPv2 pan-cancer AAC -0.072 0.05
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.05
mRNA Vandetanib CTRPv2 pan-cancer AAC -0.07 0.05
mRNA MS-275 gCSI pan-cancer AAC -0.099 0.05
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC -0.064 0.05
mRNA QS11 CTRPv2 pan-cancer AAC 0.13 0.05
mRNA GW-405833 CTRPv2 pan-cancer AAC -0.064 0.05
mRNA Erlotinib gCSI pan-cancer AAC -0.1 0.05
Download CSV